Dr. Reddy's raises after getting EIR for API manufacturing facility in Hyderabad
Dr. Reddy's Laboratories is currently trading at Rs 1127.65, up by 1.10 points or 0.10% from its previous closing of Rs 1126.55 on the BSE.
The scrip opened at Rs 1131.85 and has touched a high and low of Rs 1136.15 and Rs 1122.10 respectively. So far 12489 shares were traded on the counter.
The BSE group 'A' stock of face value Rs 1 has touched a 52-week high of Rs 1420.20 on 21-Aug-2024 and a 52-week low of Rs 1120.01 on 04-Jun-2024.
Last one week high and low of the scrip stood at Rs 1174.80 and Rs 1122.10 respectively. The current market cap of the company is Rs 94371.46 crore.
The promoters holding in the company stood at 26.64%, while Institutions and Non-Institutions held 49.74% and 10.38% respectively.
Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) for API manufacturing facility (CTO-2) in Bollaram, Hyderabad. Earlier, the inspection was conducted by the United States Food & Drug Administration (USFDA) at this facility. The USFDA has classified the inspection as Voluntary Action Indicated (VAI) and concluded that the inspection is ‘closed’ under 21 CFR 20.64(d)(3).
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
